Pobresa, Albert C.
HRN: 20-06-46 Sex: MalePatient Encounter
AMS Audit List
Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
07/29/2022
CO-AMOXICLAV 625MG (TAB)
07/29/2022
08/05/2022
PO
625
BID
Avulsed Wound
Waiting Final Action